1-4 of 4
Andrew L. Gilman, MD
Close
Sort by
Journal Articles

Post-Transplant Donor Lymphocyte Infusion with Methotrexate Prophylaxis Is Associated with Low Incidence of Relapse after CD34-Selected, T Cell-Depleted Haploidentical Donor Stem Cell Transplantation Regardless of NK Alloreactivity

Michael J Eckrich, MD MPH, Stacy Epstein, PharmD, Carrie Barnhart, RN, Javier Oesterheld, MD, Darci Grochowski, PA, Mark Cannon, BA, Andrew L Gilman, MD
Journal: Blood
Blood (2015) 126 (23): 3166.
https://doi.org/10.1182/blood.V126.23.3166.3166
Published: 2015
Journal Articles

Inflammatory Markers and Autoantibodies That Correlate with Early and Late Onset of New Onset Pediatric Chronic Graft-Versus-Host Disease (GVHD).

Hisaki Fujii, MD, Kevin She, MSc, Soudabeh Aslanian, BSc, Hiromi Shimizu, BSc, Mark Krailo, PhD, Zhengjia Chen, MS, Frederick Goldman, MD, PhD, Donna A. Wall, MD, PhD, Andrew L. Gilman, MD, Kirk R. Schultz, MD
Journal: Blood
Blood (2006) 108 (11): 3232.
https://doi.org/10.1182/blood.V108.11.3232.3232
Published: 2006
Journal Articles

Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study.

David A. Jacobsohn, MD, Kirk R. Schultz, MD, Frederick Goldman, MD, Donna A. Wall, MD, Mark Krailo, PhD, Zhengjia Chen, MS, Jeffrey M. Lipton, MD, PhD, Jean E. Sanders, MD, Andrew L. Gilman, MD
Journal: Blood
Blood (2005) 106 (11): 5375.
https://doi.org/10.1182/blood.V106.11.5375.5375
Published: 2005
Journal Articles

An Exaggerated B Cell CpG Response in Human Chronic Graft-versus-Host Disease: A Potential Mechanism and Biomarker for Diagnosis of Chronic GVHD.

Kevin She, BA, Andrew L. Gilman, MD, Kirk R. Schultz, MD
Journal: Blood
Blood (2004) 104 (11): 4966.
https://doi.org/10.1182/blood.V104.11.4966.4966
Published: 2004